<DOC>
	<DOCNO>NCT02762721</DOCNO>
	<brief_summary>The primary objective study estimate frequency FGFR2 fusion archive intrahepatic cholangiocarcinoma ( iCCA ) mix hepatocellular-cholangiocarcinoma ( HCC-CCA ) tumor sample</brief_summary>
	<brief_title>Analysis Oncogenes Intrahepatic Cholangiocarcinoma Mixed Hepatocellular-Cholangiocarcinoma Tumor Tissue Samples</brief_title>
	<detailed_description>This non-interventional , observational study archive human tissue sample ; surgical procedure require treatment provide part study . Approximately 150 archive tissue sample obtain patient iCCA mixed HCC-CCA analyze somatic alteration status include cholangiocarcinoma-specific FGFR2 fusion isoforms .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>If require law local regulation ( i.e. , sample identifiable subject ) , sign write informed consent grant prior use sample study â‰¥ 18 year age Histologically cytologically confirm iCCA mixed HCCCCA , are/were eligible systemic therapy ( sample collect prior initiation systemic therapy may submit test ) Have one formalin fix paraffin embed block available . If block evaluable , 710 unstained , nonbaked slide 5micron thick section least 20 % tumor tissue available . ( Potential participant schedule undergo surgical treatment may agree provide surplus tissue require diagnosis provide inform consent prior surgery . ) Not applicable : Patients must meet inclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>FGFR2 fusion</keyword>
	<keyword>iCCA</keyword>
	<keyword>mixed HCC-CCA</keyword>
	<keyword>Intrahepatic Cholangiocarcinoma</keyword>
	<keyword>Mixed Hepatocellular Cholangiocarcinoma</keyword>
	<keyword>Cholangiocarcinoma</keyword>
	<keyword>ArQule</keyword>
</DOC>